Shih, Ie-Ming

ARID1A Mutations in Endometriosis-Associated Ovarian Carcinomas

Wiegand, K. C., Shah, S. P., Al-Agha, O. M., Zhao, Y., Tse, K., Zeng, T., Senz, J., McConechy, M. K., Anglesio, M. S., Kalloger, S. E., et al. (2010) · New England Journal of Medicine

Chromatin Remodeling and CancerOvarian cancer diagnosis and treatment

Cited by 1,712

TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal

Killela, P. J., Reitman, Z. J., Jiao, Y., Bettegowda, C., Agrawal, N., Diaz, L. A., Friedman, A. H., Friedman, H., Gallia, G. L., Giovanella, B. C., et al. (2013) · Proceedings of the National Academy of Sciences

Telomeres, Telomerase, and SenescenceCancer-related molecular mechanisms research

Cited by 1,368

Ovarian Tumorigenesis

Shih, I.-M., & Kurman, R. J. (2004) · The American Journal of Pathology

Ovarian cancer diagnosis and treatmentBRCA gene mutations in cancer

Cited by 1,206

Proteogenomic Analysis of Human Colon Cancer Reveals New Therapeutic Opportunities

Vasaikar, S., Huang, C., Wang, X., Petyuk, V. A., Savage, S. R., Wen, B., Dou, Y., Zhang, Y., Shi, Z., Arshad, O. A., et al. (2019) · Cell

Advanced Proteomics Techniques and ApplicationsCancer Genomics and Diagnostics

Cited by 799

Cancer-associated mutations in endometriosis without cancer

Anglesio, M. S., Papadopoulos, N., Ayhan, A., Nazeran, T. M., Noë, M., Horlings, H. M., Lum, A., Jones, S., Senz, J., Seckin, T., et al. (2017) · New England Journal of Medicine

Endometriosis Research and TreatmentCancer Genomics and Diagnostics

Cited by 628

ARID1A Deficiency Impairs the DNA Damage Checkpoint and Sensitizes Cells to PARP Inhibitors

Shen, J., Peng, Y., Wei, L., Zhang, W., Yang, L., Lan, L., Kapoor, P., Ju, Z., Mo, Q., Shih, I.-M., et al. (2015) · Cancer Discovery

Chromatin Remodeling and CancerPARP inhibition in cancer therapy

Cited by 522

Prevalence of the Alternative Lengthening of Telomeres Telomere Maintenance Mechanism in Human Cancer Subtypes

Heaphy, C. M., Subhawong, A. P., Hong, S.-M., Goggins, M. G., Montgomery, E. A., Gabrielson, E., Netto, G. J., Epstein, J. I., Lotan, T. L., Westra, W. H., et al. (2011) · The American Journal of Pathology

Telomeres, Telomerase, and SenescenceGenetics, Aging, and Longevity in Model Organisms

Cited by 516

Patterns of p53 Mutations Separate Ovarian Serous Borderline Tumors and Low- and High-grade Carcinomas and Provide Support for a New Model of Ovarian Carcinogenesis: A Mutational Analysis With Immunohistochemical Correlation

Singer, G., Stöhr, R., Cope, L., Dehari, R., Hartmann, A., Cao, D.-F., Wang, T.-L., Kurman, R. J., & Shih, I.-M. (2005) · American Journal of Surgical Pathology

Ovarian cancer diagnosis and treatmentBRCA gene mutations in cancer

Cited by 408

Evaluation of DNA from the Papanicolaou test to detect ovarian and endometrial cancers.

Kinde, I., Bettegowda, C., Wang, Y., Wu, J., Agrawal, N., Shih, I.-M., Kurman, R., Dao, F., Levine, D. A., Giuntoli, R., et al. (2013) · Science Translational Medicine

Cancer Genomics and DiagnosticsCervical Cancer and HPV Research

Cited by 327

Apolipoprotein E is required for cell proliferation and survival in ovarian cancer

Chen, Y.-C., Pohl, G., Wang, T.-L., Morin, P. J., Risberg, B., Kristensen, G. B., Yu, A., Davidson, B., & Shih, I.-M. (2005) · Cancer Research

Ovarian cancer diagnosis and treatmentCancer, Lipids, and Metabolism

Cited by 155

Molecular Pathogenesis of Ovarian Borderline Tumors: New Insights and Old Challenges

Shih, I.-M., & Kurman, R. J. (2005) · Clinical Cancer Research

Ovarian cancer diagnosis and treatmentBRCA gene mutations in cancer

Cited by 142

Novel cancer treatment paradigm targeting hypoxia-induced factor in conjunction with current therapies to overcome resistance

Kao, T.-W., Bai, G.-H., Wang, T.-L., Shih, I.-M., Chuang, C.-M., Lo, C.-L., Tsai, M.-C., Chiu, L.-Y., Lin, C.-C., & Shen, Y.-A. (2023) · Journal of Experimental & Clinical Cancer Research

Cancer, Hypoxia, and MetabolismAngiogenesis and VEGF in Cancer

Cited by 89

Treating ARID1A mutated cancers by harnessing synthetic lethality and DNA damage response

Mandal, J., Mandal, P., Wang, T.-L., & Shih, I.-M. (2022) · Journal of Biomedical Science

Chromatin Remodeling and CancerPARP inhibition in cancer therapy

Cited by 84

Cell cycle-dependent alteration in NAC1 nuclear body dynamics and morphology

Wu, P.-H., Hung, S.-H., Ren, T., Shih, I.-M., & Tseng, Y. (2011) · Physical Biology

Microtubule and mitosis dynamicsNuclear Structure and Function

Cited by 32